小黃鴨德盈(02250.HK)擬認購深圳隱藏哇偶文化科技20%權益
格隆匯4月6日丨小黃鴨德盈(02250.HK)宣佈,公司間接全資附屬公司德盈商貿(深圳)有限公司("德盈商貿")、黃嘉樂、深圳嗨燈屋文化合夥企業(有限合夥)("嗨燈屋")及深圳隱藏哇偶文化科技有限公司("目標公司")於2023年4月6日簽訂投資合同,據此,德盈商貿同意以人民幣700萬元的代價(其中部分將用於集團旗下IP系列盲盒和潮流玩具的研發、銷售成本及費用)申購目標公司經擴大後股本權益的20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.